Chronic Scrotal Pain: The Complete Guide to Diagnosis, Treatment, and Recovery for Men

[Nelson Vergel]

Everything You Need to Know About Orchialgia - From Conservative Care to Advanced Microsurgery
Curated By Nelson Vergel | ExcelMale.com | Updated April 2026​

Key Takeaways • Chronic scrotal pain (CSP) affects over 100,000 men annually and accounts for roughly 2.5% of all urology visits - yet up to half of cases have no identifiable cause. • The 2025 AUA Guidelines - the first-ever evidence-based guidelines for male pelvic pain - now provide a structured roadmap for diagnosis and treatment. • Wallerian degeneration (nerve fiber breakdown) has been found in 84% of CSP patients, shifting the paradigm from "it's in your head" to a recognized neuropathic condition. • Microsurgical denervation of the spermatic cord (MDSC) is the gold standard surgical treatment, with success rates of 76 - 100% in properly selected patients. • Men on TRT should know that low testosterone and vitamin B12 deficiency are surprisingly common in chronic orchialgia patients - and correcting these deficiencies improves pain in over 80% of cases. • A spermatic cord block is both a treatment and the single best predictor of surgical success - don't skip this step.

Introduction: A Pain That Too Many Men Suffer in Silence​

Have you ever dealt with a persistent, nagging ache in your testicles that just won't go away? If so, you're far from alone - and you shouldn't have to "just live with it." Chronic scrotal pain (CSP), also known as orchialgia, is one of the most underdiagnosed and under-discussed conditions in men's health. It's defined as constant or intermittent scrotal pain lasting more than three months, and it's estimated to affect well over 100,000 men every year in the United States. The condition accounts for roughly 2.5% to 4.8% of all outpatient urology visits and costs the healthcare system around $55 million annually. Despite those numbers, most men suffering from CSP report seeing an average of 4.5 different physicians and undergoing more than seven diagnostic tests before they find meaningful relief.

The frustration runs deeper than just the number of doctor visits. For decades, when no obvious structural cause could be found - which happens in 25 - 50% of all cases - patients were told their pain was psychological, or worse, that nothing could be done. That era is ending. In April 2025, the American Urological Association (AUA) released its first-ever comprehensive guidelines for male chronic pelvic pain, including chronic scrotal content pain (CSCP). This landmark publication provides clinicians with a structured, evidence-based framework for diagnosing and treating this complex condition. Meanwhile, advances in microsurgery, neuromodulation, and our understanding of nerve pathology have opened treatment pathways that simply didn't exist a generation ago.

This guide brings together the latest clinical research, the new AUA guidelines, and practical wisdom from the ExcelMale community to give you a comprehensive, actionable resource. Whether you're experiencing testicular pain for the first time, dealing with post-vasectomy discomfort, or managing pain alongside TRT, the information here can help you work with your doctor toward real solutions.

What Is Chronic Scrotal Pain?​

Chronic scrotal pain is an umbrella term that covers pain originating from the testis itself, the epididymis (the coiled tube where sperm mature), the vas deferens (the tube that transports sperm), or adjacent paratesticular structures. To qualify as "chronic," the pain must persist for at least three months and significantly interfere with daily activities - whether that means difficulty sitting at your desk, discomfort during exercise, or problems with sexual function.
It's important to distinguish CSP from acute scrotal pain, which is a urological emergency. When testicular pain first appears, doctors must rule out time-sensitive conditions like testicular torsion (where the spermatic cord twists and cuts off blood supply), Fournier's gangrene (a life-threatening infection), or an incarcerated hernia. These conditions demand immediate intervention. Once emergencies are ruled out and the pain persists beyond the three-month threshold, the patient enters the chronic pain management pathway.

Who Gets CSP and Why?​

Most men with chronic orchialgia present in their mid-to-late 30s, though the condition can strike at any age from adolescence onward. Several factors increase risk. Men who have had a vasectomy carry about a 15% average incidence of developing chronic scrotal pain afterward - and the technique matters. Traditional scalpel vasectomy carries a roughly 24% incidence, while no-scalpel techniques drop that to around 7%. Inguinal hernia repair is another common trigger, with chronic pain developing in 3 - 6% of patients. Other recognized causes include infection (epididymitis), varicocele, trauma, and hydrocele. But here's the catch: in a large number of men, no clear cause is ever identified.

Among conditions commonly associated with orchialgia, researchers have documented varicocele in roughly 8.8% of cases, infertility in 9.7%, mid-ureteral stones in 7.1%, chronic prostatitis in 5.3%, and lumbar pain in 4.4%. Pain can also be referred from other sources - a kidney stone, a hip joint problem, or even thoracolumbar junction syndrome can masquerade as testicular pain. This complexity is exactly why a thorough, systematic evaluation matters so much.

The Science Behind the Pain: Why Nerves Are the Real Story​

For years, the lack of a visible structural problem led many clinicians to dismiss CSP as psychosomatic. That view has been upended by research into Wallerian degeneration - the breakdown of nerve fibers following injury. In a landmark study of 56 men, researchers discovered that 84% of CSP patients showed Wallerian degeneration in one or more spermatic cord nerve fibers, compared to just 20% of controls. This degeneration was concentrated in three key areas: the cremasteric muscle fibers, perivasal tissues, and posterior peri-arterial tissue - a pattern researchers have dubbed the "trifecta nerve complex."

What does this mean in practical terms? When a nerve fiber degenerates after an injury (whether from surgery, trauma, or infection), it doesn't simply go quiet. Instead, the damaged nerve can become hypersensitive, sending pain signals long after the original tissue has healed. A related concept called central sensitization explains how persistent peripheral nerve signals can make the spinal cord itself become hyper-excitable - amplifying pain signals that would normally be filtered out. Some researchers describe this as a "two-hit" model: a baseline inflammatory or genetic vulnerability sets the stage, and a second event (like a vasectomy or hernia repair) tips the system into a chronic pain state.

The primary nerves involved are the ilioinguinal nerve (traveling through the inguinal canal and providing sensation to the upper-medial thigh and scrotum) and the genitofemoral nerve (whose genital branch enters the spermatic cord). The pudendal nerve covers the posterior scrotum. Understanding this neural map is essential because it guides both diagnostic nerve blocks and surgical denervation - you can't fix what you can't locate.

Getting the Right Diagnosis: A Step-by-Step Approach​

The 2025 AUA Guidelines emphasize that chronic scrotal content pain is a diagnosis of exclusion. That means your doctor needs to systematically rule out other causes before landing on CSP. Here's what a proper workup should include.

History and Physical Examination​

A thorough history covers prior scrotal, inguinal, or pelvic surgeries; any history of trauma; sexual history; and an honest assessment of psychological distress (which can worsen pain perception). The physical exam should be performed in both standing and supine positions, checking for masses, varicoceles, hernias, and - crucially - pelvic floor muscle tenderness. The 2025 AUA Guidelines specifically recommend that clinicians perform digital palpation of the pelvic floor through a rectal exam, because pelvic floor myalgia (muscle pain) is found in 17.6% of CSCP patients and is even more common in men with broader chronic pelvic pain.

Imaging and Lab Work​

A scrotal ultrasound is frequently ordered. While it's often normal - one study found normal results in 77 of 111 cases - it serves two important purposes. First, it rules out serious pathology like tumors. Second, it provides psychological reassurance, which can be genuinely therapeutic for anxious patients. Urinalysis checks for occult infection or inflammatory markers. Your clinician should also screen for musculoskeletal issues of the hip, pelvis, and lower spine, since hip joint pathology is a documented source of misdiagnosed scrotal pain.

The COSI Score: Measuring What Matters​

The Chronic Orchialgia Symptom Index (COSI) is a validated 12-question tool that measures pain, sexual symptoms, and quality of life on a standardized scale. The AUA now recommends validated questionnaires like the COSI to establish a baseline and track treatment response. If your doctor doesn't use a structured pain assessment tool, ask about it - it's the difference between "my pain is bad" and a quantifiable score that guides treatment decisions.

The Hormone and Nutrient Connection: Don't Skip This​

Here's something that should interest every man reading this on ExcelMale: a study published in the American Journal of Men's Health found that among 125 men evaluated for chronic testicular pain, a striking 76% had deficiencies in testosterone (total T below 300 ng/dL, or free T below 46 pg/mL) and/or vitamin B12 (below 400 pg/mL). When those deficiencies were corrected, over 80% of patients with adequate follow-up reported meaningful improvement in pain. For men already on TRT, this finding reinforces the importance of keeping your testosterone optimized - and it raises a red flag about B12 status that most doctors overlook in the context of scrotal pain.

Treatment: The Step-Ladder Approach​

Effective CSP management follows a graduated pathway, starting with the least invasive options and escalating only when necessary. The 2025 AUA Guidelines reinforce this multimodal, multidisciplinary model.

Step 1: Conservative and Medical Management​

First-line treatment addresses inflammation, nerve sensitization, and musculoskeletal contributors simultaneously.

Treatment	Details	Expected Outcomes
NSAIDs (e.g., ibuprofen)	2 - 4 week trial	Reduces inflammatory component; often first step
Empirical antibiotics	1 month trial if infection cannot be ruled out	Appropriate when focal epididymal or prostatic tenderness is present
Nortriptyline (TCA)	4 - 6 week trial	66.6% achieve >50% pain improvement
Gabapentin (anticonvulsant)	4 - 6 week trial	61.5% achieve >50% pain improvement
Muscle relaxants (terazosin, baclofen)	3-month trial	Significant reduction in symptom scores
Pelvic floor physical therapy	Ongoing	Targets the 10 - 17% with musculoskeletal origin
Cognitive behavioral therapy	As needed	Addresses anxiety, depression, and coping strategies

A clinical pearl for the post-vasectomy group: Neuropathic medications like gabapentin and nortriptyline work well for general CSP, but they're significantly less effective in post-vasectomy pain syndrome (PVPS), where patients consistently show less than 50% improvement. If you developed pain after a vasectomy, your doctor should consider faster escalation to interventional options.

Pelvic floor physical therapy deserves special emphasis. The AUA Guidelines specifically recommend assessment for pelvic floor myalgia in all men with chronic pelvic pain. When you consider that 10 - 17% of CSP cases have a musculoskeletal component - pain localized to the conjoint tendon, adductor tendons, or pelvic floor - specialized physical therapy offers a low-risk, high-reward intervention that's often overlooked.

Step 2: The Spermatic Cord Block - Diagnosis and Treatment in One​

If conservative measures don't provide adequate relief, the spermatic cord block becomes your most important next step. The procedure involves injecting a local anesthetic (typically bupivacaine) into the spermatic cord at the level of the pubic tubercle. It serves a dual purpose: it provides temporary pain relief, and - more importantly - it predicts whether surgical denervation will work.

A positive response to the block (at least 50% pain reduction) is the single most reliable predictor of surgical success. In large retrospective studies, repeated blocks (averaging about 3.6 injections) led to complete resolution in roughly 36% of patients and partial relief in another 45%, with overall success rates ranging from 36 - 80% depending on how success is defined.

What about Botox injections? While a pilot open-label trial showed a 56% success rate, a subsequent randomized controlled trial found no advantage of Botox over local anesthesia alone. The effect appeared to be largely related to the injection technique itself rather than any specific benefit of the botulinum toxin.

Step 3: Microsurgical Denervation - The Gold Standard​

For men who respond to cord blocks but need a permanent solution, Microsurgical Denervation of the Spermatic Cord (MDSC) is the definitive treatment. Using high-power magnification, the surgeon carefully divides the nerve fibers (including the ilioinguinal and genitofemoral nerves) at the inguinal ring while preserving the testicular artery, lymphatics, and veins. You keep your testicle; you lose the pain.
The numbers speak for themselves. Across multiple studies, MDSC achieves complete or significant pain relief in 76 - 100% of properly selected patients. The testicular atrophy risk is less than 1%, and testosterone levels don't appear to be affected. A 2025 study of patients who remained symptomatic after varicocelectomy found MDSC relieved pain in 84.4%, with over half achieving near-complete resolution (pain scores of 1 out of 10 or less).

Robotic-assisted MDSC has emerged as a sophisticated alternative. A large series of 860 cases by Parekattil et al. demonstrated an 83% significant reduction in pain (49% complete resolution, 34% partial improvement). The robotic platform gives surgeons enhanced visualization and allows those already comfortable with robotic surgery to apply those skills to this delicate procedure. The use of CO2 laser probes further reduces collateral thermal damage compared to standard electrocautery.

One important caveat: Post-vasectomy pain syndrome carries higher failure rates with MDSC compared to idiopathic orchialgia or pain following other surgeries. A study of 143 testicular units found that while 68% of all patients achieved complete resolution, men with PVPS had increased odds of treatment failure. This doesn't mean PVPS patients shouldn't pursue MDSC - just that expectations should be set accordingly and alternative options like vasectomy reversal (vasovasostomy) should be discussed.

When the Gold Standard Isn't Enough: Salvage and Emerging Therapies​

For the small percentage of men who don't respond to MDSC, several salvage options provide hope.

Ultrasound-Guided Cryoablation​

Targeted cryoablation of the perispermatic cord tissues uses controlled freezing to disable the genitofemoral, ilioinguinal, and inferior hypogastric nerves. Studies show a 75% reduction in visual analog scale (VAS) pain scores in patients who failed MDSC. Remarkably, outcomes improve over time - from 53% pain reduction at one month to 64% at five-year follow-up - suggesting a durable therapeutic effect.

Neuromodulation: Stimulating Relief​

Peripheral nerve stimulation involves implanting tiny leads along the ilioinguinal and genitofemoral nerve branches that deliver low-frequency electrical pulses. Case reports show dramatic results - patients dropping from 9/10 pain scores to 2/10. Spinal cord stimulation works at a higher level, "scrambling" pain signals before they reach the brain. In cases of malignancy-related scrotal pain, spinal cord stimulation has achieved 80% pain reduction and allowed patients to completely stop oral analgesics.

Orchiectomy: The Last Resort​

Removal of the testicle remains the final option - and it's important to understand that it does not guarantee pain relief. The reason: if the nervous system has become centrally sensitized, removing the organ doesn't remove the "memory" of pain. Phantom scrotal pain is real. That said, when orchiectomy is necessary, the inguinal approach yields roughly 75% success compared to about 55% for the scrotal approach. The inguinal route allows higher ligation of the spermatic cord nerves, which is the same logic that makes MDSC effective.

The TRT Connection: What Men on Testosterone Should Know​

If you're reading this on ExcelMale, there's a good chance you're either on TRT or considering it. Here's how CSP intersects with testosterone replacement.

Testicular aching on TRT is common and usually benign. When exogenous testosterone suppresses your hypothalamic-pituitary-gonadal axis, your testicles reduce endogenous production and often shrink. This process can cause a dull, transient ache that typically resolves within a few weeks to months. HCG (human chorionic gonadotropin) at 500 - 1000 IU twice weekly can maintain testicular volume and may alleviate this discomfort. As many forum members report, once testicles reach their "new normal" size, the aching usually stops.

But don't assume all testicular pain on TRT is benign. Persistent, worsening, or severe testicular pain demands the same workup any man would need - ultrasound, physical exam, and appropriate follow-up. The TRT-related ache is typically mild, bilateral, and self-limiting. Pain that's unilateral, sharp, or progressively worsening warrants urgent evaluation to rule out torsion, infection, or other pathology.

Optimize your testosterone and B12. Given that 76% of men with chronic orchialgia showed testosterone and/or B12 deficiency in the Cui and Terlecki study, men on TRT are actually in a unique position: your testosterone should already be optimized. But how's your B12? Levels below 400 pg/mL were associated with chronic pain, and correction significantly improved symptoms. Ask your doctor to check it at your next panel.

Your Practical Action Plan​

If you're dealing with chronic scrotal pain, here's a step-by-step approach to getting the right care:
• Rule out emergencies first. Any new testicular pain should be evaluated urgently to exclude torsion, infection, or tumor. Don't wait three months to see a doctor - get checked now, then monitor for chronicity.
• Find a knowledgeable urologist. Not all urologists specialize in chronic pain. Look for one familiar with the COSI scoring system, spermatic cord blocks, and microsurgical denervation. Academic medical centers are often your best bet.
• Get a thorough evaluation. This means history, bilateral physical exam (standing and supine), scrotal ultrasound, urinalysis, pelvic floor assessment, and screening for hip or spine problems.
• Check your hormones and B12. Ask for total and free testosterone, plus vitamin B12 levels. Correct any deficiencies before pursuing invasive treatments.
• Try conservative measures for at least one month. NSAIDs, neuropathic medications, pelvic floor physical therapy, and supportive underwear. Track your COSI score so you have objective data.
• Get a spermatic cord block if pain persists. This is both therapeutic and diagnostic. A positive response (50% or greater pain reduction) makes you a strong candidate for surgical denervation if needed.
• Consider MDSC if blocks help but pain returns. Success rates of 76 - 100% in block-responders make this the gold standard surgical option.
• Don't lose hope if MDSC doesn't work. Cryoablation, neuromodulation, and other salvage therapies offer additional pathways to relief.
• Address the whole picture. Chronic pain affects sleep, mood, relationships, and sexual function. Cognitive behavioral therapy, support groups, and honest conversations with your partner are all part of the solution.

Related ExcelMale Forum Discussions​

Explore these community discussions for additional insights:

Testicular Pain: Gold Standard Care of Chronic Scrotal Pain - Comprehensive review of the 2021 landmark paper covering surgical and non-surgical treatment options, with community discussion of real-world outcomes.
Current Trends and Therapies for Chronic Scrotal Pain Management - Detailed breakdown of modern treatment algorithms, from conservative therapy to microsurgical denervation and emerging options like cryoablation.
Breakthrough AUA Guidelines on Male Pelvic Pain - Discussion of the landmark 2025 AUA Guidelines with expert podcast featuring Dr. Susan MacDonald on pelvic floor dysfunction and chronic scrotal content pain.
Men with Chronic Testicular Pain May Have Low Testosterone and B-12 - Study summary and member discussion on the surprisingly high prevalence of testosterone and B12 deficiency in men with chronic orchialgia.
Spermatic Cord Injection for Chronic Scrotal Pain - Forum thread on the role of spermatic cord blocks as both a diagnostic predictor and therapeutic intervention for chronic scrotal pain.
Testicular Pain While on TRT - Community discussion about testicular aching during TRT, when it's normal, and when HCG can help address pain related to testicular atrophy.
Testicular Ache but Do Not Want to Use HCG - Practical member experiences with testicular discomfort on testosterone-only protocols and the pros and cons of adding HCG.
Novel Surgical and Non-Surgical Approaches to Chronic Orchialgia and Pelvic Pain - Overview of cutting-edge research on emerging treatment modalities for refractory chronic orchialgia.
Evaluation and Management of Chronic Scrotal Pain - Recent thread covering the latest evidence on systematic approaches to diagnosis and stepped treatment protocols.

Key References​

1. Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach. J Urol. 2025;214(2):117-126. doi:10.1097/JU.0000000000004564
2. Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain. J Urol. 2025;214(2):138-146. doi:10.1097/JU.0000000000004566
3. Sigalos JT, Pastuszak AW. Chronic orchialgia: epidemiology, diagnosis and evaluation. Transl Androl Urol. 2017;6(Suppl 1):S37-S43. doi:10.21037/tau.2017.05.23
4. Parekattil SJ, Gudeloglu A, Brahmbhatt JV, et al. Trifecta nerve complex: potential anatomical basis for microsurgical denervation of the spermatic cord for chronic orchialgia. J Urol. 2013;190(1):265-270. PMID: 23353047
5. Strom KH, Levine LA. Microsurgical denervation of the spermatic cord for chronic orchialgia: long-term results from a single center. J Urol. 2008;180(3):949-953. PMID: 18639271
6. Parekattil SJ, et al. Targeted robotic-assisted microsurgical denervation of the spermatic cord: a single center, large series review. J Urol. 2018;199(4):1015-1022. doi:10.1016/j.juro.2017.10.030
7. Cui T, Terlecki R. Prevalence of relative deficiencies in testosterone and vitamin B12 among patients referred for chronic orchialgia: implications for management. Am J Mens Health. 2016;12(3):608-613. PMID: 27059644
8. Chaudhari R, Sharma S, Khant S, Raval K. Microsurgical denervation of spermatic cord for chronic idiopathic orchialgia: long-term results from an institutional experience. World J Mens Health. 2019;37(1):78-84. doi:10.5534/wjmh.180013
9. Tuan LA, et al. Efficacy of microsurgical denervation of the spermatic cord in patients with chronic scrotal pain following unsuccessful varicocelectomy. Transl Androl Urol. 2025. doi:10.21037/tau-24-632
10. Bettencourt A, Naelitz B, Momtazi-Mar L, et al. Contemporary approaches and treatment perspectives for chronic scrotal content pain: insights from a national practice patterns survey. Int J Impot Res. 2026;38(2):86-92. doi:10.1038/s41443-025-01101-x

Medical Disclaimer​

This article is provided for educational and informational purposes only and does not constitute medical advice. The information presented here should not be used as a substitute for professional medical diagnosis, treatment, or care. Chronic scrotal pain is a complex condition that requires individualized evaluation by a qualified healthcare provider. Always consult your physician or urologist before starting, changing, or discontinuing any treatment plan. If you experience sudden, severe testicular pain, seek emergency medical attention immediately.

About ExcelMale​

ExcelMale.com is the internet's most trusted, expert-moderated community for men's health, with over 24,000 members and more than 20 years of archived discussions on testosterone replacement therapy, hormone optimization, and total wellness. Founded by Nelson Vergel - a chemical engineer, patient advocate, and author of Testosterone: A Man's Guide and Beyond Testosterone - ExcelMale bridges peer-reviewed clinical research with practical, real-world experience. Whether you're new to TRT or fine-tuning your protocol, our community provides evidence-based guidance you can trust.

 

[Nelson Vergel]

Thread 'Testicular Pain: Gold Standard Care of Chronic Scrotal Pain'

Jun 5, 2021

Introduction: Chronic scrotal pain (CSP) can be a debilitating condition for patients and is often difficult to characterize.

Methods: A review of the literature was performed using Embase, Cochrane and Medline databases in the period 1.January 2010 to 1.January 2021. We found 132 articles, and the authors screened abstract and references. Thirty-seven articles are included after removing duplicates.

Results: This review presents a variety of medical and surgical treatment options for CSP such as spermatic cord blocks (36–80% success rate), microsurgical denervation of...

• madman
• chronic scrotal pain
• Replies: 4
• Forum: Testosterone and Men's Health Articles